143 related articles for article (PubMed ID: 37036724)
1. Daratumumab for a Patient With Refractory Antineutrophil Cytoplasmatic Antibody-Associated Vasculitis.
Rixecker TM; Lepper PM; Mang S; Espig P; Brill K; Thurner L; Bittenbring JT
JAMA Intern Med; 2023 Jun; 183(6):615-618. PubMed ID: 37036724
[TBL] [Abstract][Full Text] [Related]
2. Daratumumab for the treatment of refractory ANCA-associated vasculitis.
Ostendorf L; Burns M; Wagner DL; Enghard P; Amann K; Mei H; Eckardt KU; Seelow E; Schreiber A
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36627149
[No Abstract] [Full Text] [Related]
3. Proteinase 3-antineutrophil cytoplasmic antibody-associated cutaneous vasculitis without systemic involvement.
Brown A; Watchorn RE; Cope NJ; Downs AMR
Clin Exp Dermatol; 2017 Jul; 42(5):582-584. PubMed ID: 28512743
[No Abstract] [Full Text] [Related]
4. [Benzylthiouracil-induced antineutrophil cytoplasmic antibody-associated cutaneous vasculitis: a case report and literature review].
Chebbi W; Zantour B; Alaya W; Belhadjali H; Sfar MH
Rev Med Interne; 2013 Sep; 34(9):561-4. PubMed ID: 23827012
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary involvement in antineutrophil cytoplasmic antibody-associated vasculitides.
Pella E; Iatridi F; Sgouropoulou V; Boutou A; Dimitroulas T
Int J Rheum Dis; 2024 Jan; 27(1):e14933. PubMed ID: 37753535
[No Abstract] [Full Text] [Related]
6. Treatment of Recurrent Antineutrophil Cytoplasmic Antibody-Associated Vasculitis After Kidney Transplant With Rituximab: A Successful Case Report.
Silva RM; Leal R; Marques MG; Rodrigues L; Santos L; Romaozinho C; Alves R; Figueiredo A
Exp Clin Transplant; 2023 Feb; 21(2):171-174. PubMed ID: 36919725
[TBL] [Abstract][Full Text] [Related]
7. [Current status of diagnosis and treatment for antineutrophil cytoplasmic antibody associated vasculitis].
Makino H; Sada KE
Nihon Naika Gakkai Zasshi; 2011 Mar; 100(3):668-72. PubMed ID: 21618794
[No Abstract] [Full Text] [Related]
8. Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitis.
Rutgers A; Kallenberg CG
Curr Opin Rheumatol; 2012 May; 24(3):245-51. PubMed ID: 22410545
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for rescue and maintenance therapy in rapidly progressive life-threatening antineutrophil cytoplasmic autoantibody-associated systemic vasculitis.
José RJ; Chrysochou C; Shurrab AE; New D; Wood GN
Scand J Urol Nephrol; 2010 Dec; 44(6):459-62. PubMed ID: 20645677
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls in evaluating the impact of persistent hematuria after induction therapy on kidney prognosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Taniguchi T; Hiwa R; Morinobu A
Kidney Int; 2024 Feb; 105(2):391-392. PubMed ID: 38245220
[No Abstract] [Full Text] [Related]
11. Diagnosis and management of ANCA associated vasculitis.
Berden A; Göçeroglu A; Jayne D; Luqmani R; Rasmussen N; Bruijn JA; Bajema I
BMJ; 2012 Jan; 344():e26. PubMed ID: 22250224
[No Abstract] [Full Text] [Related]
12. Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy.
Kucuk A; Solak Y; Gaipov A; Bagcaci S; Esen H; Turk S; Tunc R
Korean J Intern Med; 2016 Jan; 31(1):194-6. PubMed ID: 26767877
[No Abstract] [Full Text] [Related]
13. ANCA Vasculitis Treatment in the Dialysis Patient: Caution Needed!
Hendren E; Radhakrishnan J
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1617-1619. PubMed ID: 34750158
[No Abstract] [Full Text] [Related]
14. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Presenting Rapid Progressive Glomerulonephritis With Elevation of Serum Immunoglobulin G4.
Yamaguchi M; Katsuno T; Ito H; Iwagaitsu S; Nobata H; Kinashi H; Banno S; Kitamura H; Ito Y
J Clin Rheumatol; 2020 Oct; 26(7):e242-e245. PubMed ID: 31261310
[No Abstract] [Full Text] [Related]
15. [Pulmonary manifestations of anti-neutrophil cytoplasmic antibody associated vasculitis].
Elgueta F; Wurmann P; Mac-Namara M; Grandjean J; Ardiles L
Rev Med Chil; 2022 Apr; 150(4):505-511. PubMed ID: 36155760
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmatic antibody positive systemic vasculitis in a patient treated with propylthiouracil.
Silva SV; Ferreira JP; Carvalho S; Seabra F; Marinho A
Acta Reumatol Port; 2013; 38(4):302-5. PubMed ID: 24435037
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Visual Outcome of Refractory Retinal Vasculitis Associated With Antineutrophil Cytoplasm Antibody-Associated Vasculitides.
Lin M; Anesi SD; Ma L; Ahmed A; Small K; Foster CS
Am J Ophthalmol; 2018 Mar; 187():21-33. PubMed ID: 29258731
[TBL] [Abstract][Full Text] [Related]
18. Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy.
Hishida E; Kobayashi T; Ono Y; Oka K; Masuda T; Ueda Y; Akimoto T; Saito O; Nagata D
CEN Case Rep; 2022 Feb; 11(1):36-42. PubMed ID: 34282535
[TBL] [Abstract][Full Text] [Related]
19. Recognition of Rare, Atypical Manifestations Is Important for Diagnosis and Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Comment on the Article by Delaval et al.
Akiyama M
Arthritis Rheumatol; 2021 Apr; 73(4):719. PubMed ID: 33191641
[No Abstract] [Full Text] [Related]
20. Pulmonary fibrosis in patients with positive neutrophil cytoplasmic antibodies vasculitis.
Tomàs Chaume L; Martínez Escudé A; Ortíz-Santamaria V
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S145. PubMed ID: 26394015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
